This research was reviewed and approved by the Ethical Committee of the Pan American World Health Organization (No. PAHO-2016-08-0029) and the Brazilian Ministry of Health (MoH) as part of the arbovirus genomic surveillance efforts within the terms of Resolution 510/2016 of CONEP (Comissão Nacional de Ética em Pesquisa, Ministério da Saúde; National Ethical Committee for Research, Ministry of Health). Residual anonymized clinical diagnostic samples, with no or minimal risk to patients, were provided for research and surveillance purposes within the terms of Resolution 510/2016 of CONEP. Processing of human samples was approved and the need for participants consent was waived by the Institutional Review Board from the Fundação Oswaldo Cruz/Instituto Oswaldo Cruz (CEP/CAAE: 90249218.6.1001.5248; approval number 2.998.362).

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.